The costs of future polio risk management policies.

摘要: Decisionmakers need information about the anticipated future costs of maintaining polio eradication as a function policy options under consideration. Given large portfolio options, we reviewed and synthesized existing cost data relevant to current policies provide context for policies. We model expected different strategies continued vaccination, surveillance, other that require significant potential resource commitments. estimate portfolios low-, middle-, high-income countries demonstrate variability in these costs. global transition from routine immunization with oral poliovirus vaccine (OPV) inactivated (IPV) would increase managing globally, although IPV use remains less costly than OPV supplemental activities. The surveillance stockpile, while small compared vaccination costs, represent important expenditures ensure adequate response outbreaks. uncertainty sensitivity analyses highlight aggregated demonstrates discount rate price administration drives incremental vs. immunization.